Paul Stuka bought $18k of NSPR
director at InspireMD, Inc.. 20,000 shares at an average of $0.88, traded May 27, 2026, filed May 29, 2026.
Score components
- +15RoleDirector
- 0Trade size$18k at market
- 0Relative to holdingsHoldings up 3.1%
- +18Price context0% above the 52-week low; 68% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying4 buys in 90 days
- -5Track recordMedian 6-month excess return -63% over 6 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-026348, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 27, 2026 | POpen-market purchase Common Stock | +20,000 | $0.88 | $18k | 667,871 | May 29, 2026 |
Related signals
Other insiders at InspireMD, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 27Weak | NSPRsell InspireMD, Inc. | Shane Thomas Gleason Chief Commercial Officer | $190k 85,295 shares | -7% | |
| 48Moderate | InspireMD, Inc. | Paul Stuka director | $17k 15,000 shares | +2% | |
| 58Moderate | InspireMD, Inc. | Marvin Slosman CEO and President | $25k 21,000 shares | +1% | |
| 45Moderate | InspireMD, Inc. | Paul Stuka director | $88k 75,626 shares | +14% | |
| 45Moderate | InspireMD, Inc. | Paul Stuka director | $88k 75,626 shares | +14% | |
| 61Notable | InspireMD, Inc. | Gary S Roubin director | $106k 90,000 shares | +12% | |
| 43Moderate | InspireMD, Inc. | Paul Stuka director | $9,034 7,895 shares | +2% | |
| 68Notable | InspireMD, Inc. | Scott R. Ward director | $103k 89,250 shares | +60% | |
| 23Weak | NSPRbuy InspireMD, Inc. | Paul Stuka director | $4,905 2,710 shares | +1% | |
| 25Weak | NSPRsell InspireMD, Inc. | Shane Thomas Gleason Chief Commercial Officer | $99k 61,194 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.